Approval Date: Feb 2022
A peppermint-flavored solution indicated for the treatment of hypertension and angina. Amlodipine is available as a generic in oral tablets.
Approval Date: Feb 2022
Indicated for the treatment of spasticity resulting from multiple sclerosis, as well as in patients with spinal cord injuries or diseases.
Approval Date: Jan 2022
Indicated for the treatment of Hepatitis C genotypes 1-4 in patients without cirrhosis, or with compensated cirrhosis as part of a combination antiviral treatment regimen.
Approval Date: Jan 2022
Indicated for the treatment of insomnia, characterized by difficulties with sleep onset and/or sleep maintenance.
Approval Date: Dec 2021
Indicated to reduce the risk of HIV-1 infection
Approval Date: Dec 2021
Indicated to improve glycemic control for type 1 and 2 diabetes
Approval Date: Dec 2021
The 7th biosimilar approved for adalimumab. For the treatment of rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn’s Disease, ulcerative colitis, and plaque psoriasis
Approval Date: Nov 2021
Indicated for the treatment of seizures, and for the preventive treatment of migraine
Approval Date: Nov 2021
Indicated for the treatment of opioid-induced constipation
Approval Date: Oct 2021
Indicated for the emergency treatment of known or suspected opioid overdose